Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
about
HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.Slowing of the HIV epidemic in Ukraine: evidence from case reporting and key population surveys, 2005-2012HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in KenyaConfronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from MalaysiaHIV-1 vaccines: challenges and new perspectivesNovel directions in HIV-1 vaccines revealed from clinical trialsHarm reduction: compassionate care of persons with addictions.High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillanceTailored combination prevention packages and PrEP for young key populations.Trend of HIV/AIDS Prevalence and Related Interventions Administered in Prisons of Iran -13 Years' Experience.Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs.An HIV Vaccine for South-East Asia-Opportunities and Challenges.Policies and politics that promote HIV infection in the Southern United States.New prospects for a preventive HIV-1 vaccine.A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.Developing a Brief Scale to Measure HIV Transmission Risk Among Injecting Drug Users.Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention.Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto RicoCan combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and ZambiaCorrelates of sex trading among male non-injecting drug users in Myanmar: a cross-sectional study.Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.Mobilising a global response to hepatitis: Lessons learned from the HIV movement.What about Us? Economic and Policy Changes Affecting Rural HIV/AIDS Services and Care.Provision of harm-reduction services to limit unsafe abortion in Tanzania.Demand for programs for key populations in Africa from countries receiving international donor assistance.Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China.Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing Roles.HIV Risk Behavior Among Methamphetamine Users Entering Substance Abuse Treatment in Cape Town, South Africa.Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.Harm reduction principles for healthcare settingsHIV and adolescents: focus on young key populations.Increasing HIV testing among African immigrants in ireland: challenges and opportunities.Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.Using medical examiner case narratives to improve opioid overdose surveillance.Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico."Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
P2860
Q27687375-9998298D-2975-4ED9-BCF1-2B506D21467CQ28543178-EDABE897-BE49-407E-A4FB-4996BBE7B5A9Q28608358-A91D84B1-3610-44D5-AD8A-100DB93CF94AQ30250218-F7A2D066-A51C-4D4A-B74B-346540EFE1F5Q33577972-31272063-209B-49EA-BC03-9D0462E8EC21Q33645528-975F121C-0B10-415B-9989-A488B3CE4FD3Q33804999-3AA8458F-6998-4F25-98A5-E593F7054DFFQ35120376-3FA988B1-97D3-460F-9AC6-6A9E38A75804Q35131207-6AF9FA75-56B9-459C-B624-EE3925C4988EQ35612794-FFB2A856-4BDE-494E-93AD-86D6BD019DCCQ35749923-A59C8ADC-23C6-47DC-BCC6-3FA9A340BC18Q35826681-4CF6C8BA-FE84-4BC5-B4FB-B23DC6EB8627Q35843388-E65DED2C-EA62-41FE-AACF-2BA189B00025Q36223864-16A6E853-01EF-4B23-ABC0-EE35A19EBBE1Q36552540-1C584746-FAA0-4DD9-9E7D-075C07739586Q36555006-5F20F603-98AF-4CC4-88E2-49E61435C9A1Q36641585-779BA35C-03A9-498D-9284-C01FE1E84C11Q36668343-9CC1A898-C7C7-4682-B5AB-09074D1A4A24Q37083998-3D378EA3-5D05-4D49-9C67-D6417E246D72Q37476561-47EBD829-7A4F-4C01-801A-63062E685CBDQ38623266-09C72D0F-B777-4991-982C-E66C3C99F696Q38810895-157CDB5D-EC2E-4CBA-B1EC-4908D9E367B8Q38918569-995C57F1-5C6A-4B55-93D1-B0DCEDAF88A8Q39014434-31A34DEF-3614-4678-9C70-822B4F6417CDQ39415690-FE9B518B-B578-4517-9476-82E78D251E86Q40042274-68E1E751-BC4C-4394-8269-0A8EF80914F2Q40232737-52A4F710-1F60-4BAA-A196-A7F2B3C41814Q41629143-99B12AB3-5F30-45AC-9054-C13495CAA20CQ41713792-6F223F6F-CB33-4D3C-A107-FB003A299002Q42634280-C3D49797-F300-4521-A362-834AB57527E3Q46119171-77E31639-1C96-44D7-8F6D-DD2A152E96D6Q46417944-EA5C2128-AB32-47CA-9F1A-6AE055E2A69DQ47570818-C1FEDD00-FF3C-4940-865F-2264D00BCA29Q49901726-4A280D23-D6CB-48CB-8BA5-8D84F574C88BQ51747535-FD6AD652-7471-4BDB-8C75-2E7FE160C5E4Q55346664-19D1FB5C-406A-430E-B07E-3EE4DB9F8200
P2860
Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Key harm reduction interventio ...... e and middle-income countries.
@en
type
label
Key harm reduction interventio ...... e and middle-income countries.
@en
prefLabel
Key harm reduction interventio ...... e and middle-income countries.
@en
P2093
P1476
Key harm reduction interventio ...... me and middle-income countries
@en
P2093
Andrea L Wirtz
Chris Beyrer
Farley R Cleghorn
P304
P356
10.1097/COH.0B013E328354A0B5
P577
2012-07-01T00:00:00Z